Compounds of formula (I) (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described.
本文介绍了
化学式(I)的化合物(其中变量基团的定义如上所述),其药学上可接受的盐、此类盐的溶剂化合物、溶剂化合物的前药及其作为治疗高脂血症的
胆固醇吸收
抑制剂的用途。本文还介绍了它们的制造过程和含有它们的制药组合物。